Company Overview
Snapshot
Founded in September 2025 by Michael Gavshin, GlucoSonic operates with 1–10 employees. The company has secured funding across two rounds and received a grant in January 2026.
Business overview
GlucoSonic is developing an ultrasonic-based sensing technology for non-invasive physiological monitoring, primarily focusing on glucose level measurement. Its core technology utilizes acoustic spectroscopy combined with compensation algorithms for temperature and sensor distance variations. The company designs its system as a hardware and signal-processing platform, intended for integration into medical and consumer monitoring devices, serving the global Health Tech & Life Sciences sector.
Log in to access full profile ›Company Intelligence Q&A
- What is GlucoSonic's primary focus?
- GlucoSonic's primary focus is the development of an ultrasonic-based sensing technology for non-invasive physiological monitoring, specifically for measuring glucose levels using acoustic spectroscopy.
- When was GlucoSonic founded?
- GlucoSonic was founded in September 2025.
- Who is the founder of GlucoSonic?
- Michael Gavshin is the founder of GlucoSonic.
- What type of product does GlucoSonic offer?
- GlucoSonic offers the GlucoSonic Sensor, a product currently in clinical trial stage, designed for non-invasive ultrasonic glucose monitoring.
- What markets does GlucoSonic target?
- GlucoSonic targets global markets, including Africa, Europe, Americas, and Asia, with its non-invasive physiological monitoring technology.